The insider's sell-off could be interpreted in various ways. It could be a personal financial decision or a response to the company's current valuation. However, it's crucial to note that insider ...
In a recent transaction, Cassie Jung, the Chief Operating Officer of Aquestive Therapeutics , Inc. (NASDAQ: AQST), sold a small portion of the company's stock. The transaction, which took place on ...
On the same day, Jung also exercised options to acquire 25,000 shares of Aquestive Therapeutics at an exercise price of $3.1027, for a total value of $77,567. These options were granted on June 10, ...
Cassie Jung, Chief Operating Officer of Aquestive Therapeutics, Inc. (NASDAQ:AQST), sold 62,180 shares of common stock at a price of $5.00 on September 4, 2025, for a total value of $310,900. The ...
Cassie Jung, Chief Operating Officer (COO) von Aquestive Therapeutics, Inc. (NASDAQ:AQST), hat am 4. September 2025 insgesamt 62.180 Stammaktien zu einem Kurs von 5,00 $ veräußert. Das Gesamtvolumen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results